期刊文献+

MiR-100对肝癌细胞有丝分裂阻滞及Polo样激酶1蛋白表达的作用 被引量:3

Effects of microRNA-100 on mitosis block and Polo-like kinase 1 expression in hepatocellular carcinoma cells
下载PDF
导出
摘要 目的探讨microRNA-100(miR-100)对肝癌细胞有丝分裂阻滞及Polo样激酶1(PLK1)表达的作用。方法采用实时定量PCR和免疫荧光方法检测miR-100和PLK1在人肝癌细胞HepG2中的表达。利用Oligofectamine脂质体介导将Cy3荧光标记的miR-100模拟物瞬时转染HepG2细胞,分析细胞有丝分裂和PLK1蛋白表达情况。结果肝癌细胞HepG2的miR-100表达量低于正常肝细胞,而PLK1 mRNA和蛋白表达却异常升高。在miR-100模拟物转染后48h,实验组细胞有丝分裂指数显著小于对照细胞,经Western blotting分析显示,实验组细胞PLK1蛋白表达水平较对照组细胞均显著减低。同时免疫细胞化学检测发现,在有丝分裂中晚期和末期位于细胞核内的PLK1蛋白基本消失。结论 miR-100具有抑制PLK1蛋白表达的作用,可引起肝癌细胞有丝分裂阻滞。 Objective To investigate the effect of microRNA-100 (miR-100) on mitosis block and Polo-like kinase 1 (PLK1) expression in hepatocellular carcinoma cells. Methods Expression of miR-100 and PLK1 was determined by quantitative real-time PCR (qRT-PCR) and immunofluorescence (IF) in hepatocellular carcinoma HepG2 cells. HepG2 cells were transiently transfected by miR-100 mimic with Cy3 fluorescence labeled through Oligofectamine liposomes, followed by cell mitosis and PLK1 expression analysis. Results Expression level of miR-100 decreased whereas PLK1 mRNA and protein expression abnormally increased in HepG2 cells compared with the normal hepatocytes. At 48hours after transfection of miR-100 mimic, the mitotic index of HepG2 cells in experimental group was significantly less than that of control cells. Western blotting analysis indicated that PLK1 protein expression levels were significantly reduced in experimental cells compared with the control ceils. Immunocytochemical results showed that PLK1 protein in the nucleus almost disappeared in meta/ana-phase and telophase of mitosis. Conclusion MiR-100 may inhibit the expression of PLK1 protein, which leads to mitotic block of hepatocellular carcinoma cells.
出处 《解剖学报》 CAS CSCD 北大核心 2014年第1期70-73,共4页 Acta Anatomica Sinica
基金 河南省杰出青年科学基金资助项目(0512000800)
关键词 肝癌 有丝分裂 microRNA-100 POLO样激酶1 实时定量PCR 免疫印迹法 免疫荧光 Hepatocellular carcinoma Mitosis MicroRNA-100 Polo-like kinase 1 Real-time quantitativePCR Western blotting Immunofluorescence
  • 相关文献

参考文献12

  • 1Peng DX, Luo M, Qiu LW, et al. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer [J]. Oncol Rep, 2012, 27(4) :1238-1244.
  • 2Leite KR, Tomiyama A, Reis ST, et al. MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer [J]. J Urol, 2011,185(3) :1118-1122.
  • 3邸菁,柏树令,张凌志,高杰,佟浩.Polo样激酶1在大鼠心肌细胞分化过程中的表达[J].解剖学报,2008,39(4):578-581. 被引量:3
  • 4Li BH, Zhou JS, Ye F, et al. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein [J]. Eur J Cancer, 2011, 47 (14) : 2166- 2174.
  • 5Ng WL, Yan D, Zhang X, et al. Over-expression of miR -100 is responsible for the low- expression of A TM in the human glioma cell line: M059J [J]. DNA Repair, 2010, 9 (11) : 1170-1175.
  • 6de Oliveira JC, Scrideli CA, Brassesco MS, et al. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features [J]. Leuk Res, 2012,36(3) :29329-29338.
  • 7Lera RF, Burkard ME. High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells[J]. J Biol Chern, 2012, 287(51): 42812-42825.
  • 8Pellegrino R, Calvisi DF, Ladu S, et al. Oncogenic and tumor suppressive roles of Polo-like kinases in human hepatocellular carcinoma [J]. Hepatology, 2010, 51(3): 857-868.
  • 9He Z, Wu J, Dang H, et al. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of survivin expression [J]. Cancer Lett, 2011, 303(2) :92-98.
  • 10Han DP, Zhu QL, Cui JT, et al. Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells [J]. Med Sci Monit, 2012, 18 (6) :237- 246.

二级参考文献10

  • 1Anversa P, Leri A, Kajstura J. Cardiac regeneration[J]. J Am Coil Cardiol, 2006, 47(9): 1769-1776.
  • 2Anversa P, Kajstura J, Leri A, et al. Life and death of cardiac stem cells: a paradigm shift in cardiac hiology[J]. Circulation, 2006, 113(11): 1451-1463.
  • 3Nigg EA. Polo-like kinases: positive regulators of cell division from start to finish[J]. Curr Opin Cell Biol, 1998, 10(6) :776-783.
  • 4Reagan-Shaw S, Ahmad N. Polo-like kinase (plk) 1 as a target for prostate cancer managemen[J]. IUBMB Life, 2005, 57(10) :677-682.
  • 5Syed N, Smith P, Sullivan A, et al. Transcriptional silencing of Pololike kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies [J]. Blood, 2006, 107(1) :250-256.
  • 6Van-vugt MA, Bras A, Medema RH. Polo-like Kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells[J]. Mol Cell, 2004, 15(5) :799-811.
  • 7Georgescu SP, Komuro 1, Hiroi Y, et al. Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocfles[ J]. J Mol Cell Cardiol, 1997, 29(3) :929-937.
  • 8Mclnnes C, Mazumdar A, Mezna M, et al. lnhibitors of Polo-like kinase reveal roles in spindle-pole maintenance[J]. Nat Chem Biol, 2006, 2(11) :608-617.
  • 9Strebhardt K. Small molecules keep mitotic kinases in check[J]. ACS Chem Biol, 2006, 1 (11) :683-686.
  • 10Soonpaa MH, Kim KK, Pajak L, et al. Cardiomyocyte DNA synthesis and binucleation during murine development[J]. Am J Physiol, 1996, 271 (5 Pt 2) :2183-2189.

共引文献2

同被引文献7

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部